The paperwork problem begins before anyone fills in a form. A family notices the missed bills, the repeated questions, the burner left on. They want help at home, someone for a few hours, a shower chair, a nurse who visits. In the United States, the payer of last resort and first resort for that kind of help is Medicaid, which the commentary describes as the primary payer for home and community-based services, supporting 4.5 million Americans. And for many working-age or non-elderly applicants, the road into Medicaid runs through the disability category. That road, the authors point out, has a gate: applicants must receive a disability determination through the Social Security Administration or a state agency, and the disability evaluation process requires a formal diagnosis.
Here is where two facts grind against each other. Underdiagnosis of dementia is widespread in the U.S., the commentary notes, especially among minoritized racial and ethnic groups, and it cites research suggesting that fewer than half of people living with dementia have been diagnosed by a clinician. Getting that diagnosis is often a long process, and people are frequently misdiagnosed, particularly those with rarer subtypes. So the requirement that establishes need is the same requirement that many people who need help cannot satisfy, or cannot satisfy quickly. The article is an opinion piece rather than a study: it reports no new patient data, and it does not count how many people are turned away. What it does is map the geometry of the gate.
Beyond the gate, the ground is uneven by design. Nearly all home and community-based services are optional benefits under Medicaid, the authors write; states are required to cover only a subset classified as home health services, meaning part-time nursing, home health aide services, and medical supplies and equipment. Everything else, the attendant hours, the day programs, the respite that keeps a caregiver upright, is left largely to state discretion. Layered on top of that are the complexity of state waiver structures, state-by-state variation in policy, and each state's own eligibility determination process. The result, the commentary argues, is inconsistent and often inequitable access, a system that is not, in the Administration for Community Living's phrase that the authors borrow, dementia-capable. Difficulty obtaining a diagnosis, limited awareness of what exists, and fear of stigma come up as especially prominent barriers.
Diagnosis can also work as a key rather than a lock, which is the uncomfortable part. The authors point to Missouri, whose 1915(c) Structured Family Caregiving waiver limits eligibility to people with a dementia diagnosis, a design that channels support to families, especially in rural areas, while potentially barring people who have not yet been diagnosed. Their own recommendation on eligibility is deliberately soft-edged: states can encourage, but should not require, a diagnosis for waiver eligibility. Meanwhile the machinery is shifting. States are using Community First Choice authority and 1115 demonstrations to widen attendant and support services, several are directing new Rural Health Transformation Program money toward rural home care and caregiver support, and a 2025 federal law cited in the article will let states offer Medicaid home and community-based services without requiring people to meet an institutional level of care, provided waiting times do not grow. That pathway does not take effect until 2028, and the authors frame it as a chance for earlier intervention rather than a fix.
The sharpest claim in the piece is about seeing, not spending. Cost and outcomes research on home and community-based services has been hobbled, the authors write, by inconsistent use of evidence-based tools, a lack of standardized metrics, and state-by-state variation, which is a polite way of saying nobody can yet answer how many people living with dementia actually get help and what happens to them afterward. They argue that recent CMS initiatives such as the Access Rule may make that work possible, and they ask states for greater transparency and standard reporting metrics, including time to institutionalization. It is a modest ask with a large consequence: measurement is what would let one state learn from another, and what would let a regulator finally size the gap instead of inferring it.
For a family reading this from a kitchen table, the practical translation is not advice, it is context. The delay you are experiencing between suspecting something and holding a written diagnosis is not merely a clinical delay; in the disability pathway it can also be an administrative one, and the commentary's contribution is to say so in the language that budget writers and rule makers use. What your own state covers, what your own eligibility route is, and what any of it means for your household are questions for your clinician, your state Medicaid agency, and, if you can reach one, a benefits counselor.